Combination of oncolytic herpes simplex viruses armed with angiostatin and IL-12 enhances antitumor efficacy in human glioblastoma models. - Wikidata - wikimedia - TriplyDB

Combination of oncolytic herpes simplex viruses armed with angiostatin and IL-12 enhances antitumor efficacy in human glioblastoma models.

Combination of oncolytic herpes simplex viruses armed with angiostatin and IL-12 enhances antitumor efficacy in human glioblastoma models.

http://www.wikidata.org/entity/Q36879211

about

To Infection and Beyond: The Multi-Pronged Anti-Cancer Mechanisms of Oncolytic Viruses Sui generis: gene therapy and delivery systems for the treatment of glioblastoma Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapy Trial Watch:: Oncolytic viruses for cancer therapy Trial Watch-Oncolytic viruses and cancer therapy Unlocking the promise of oncolytic virotherapy in glioma: combination with chemotherapy to enhance efficacy Designing Herpes Viruses as Oncolytics.EXPLORING THE ANTITUMOR EFFECT OF VIRUS IN MALIGNANT GLIOMA Single agent efficacy of the VEGFR kinase inhibitor axitinib in preclinical models of glioblastoma Targeting tumor vasculature through oncolytic virotherapy: recent advances.Cancer subclonal genetic architecture as a key to personalized medicine.Clinical trials of viral therapy for malignant gliomas.Evolution of oncolytic viruses: novel strategies for cancer treatment.Oncolytic viral therapy: targeting cancer stem cells Blockade of transforming growth factor-β signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma models.In situ vaccination: Cancer immunotherapy both personalized and off-the-shelf.In situ vaccination for the treatment of cancer.Oncolytic Immunotherapy for Treatment of Cancer.Immune and viral therapies for malignant primary brain tumors.Evaluation of JC and Cytomegalo Viruses in Glioblastoma Tissue Gene Delivery in Neuro-Oncology.Therapeutic targeting of chemoresistant and recurrent glioblastoma stem cells with a proapoptotic variant of oncolytic herpes simplex virus.Immunovirotherapy for the treatment of glioblastoma.Immunovirotherapy for glioblastoma.Panorama from the oncolytic virotherapy summit.Surface biotinylation of cytotoxic T lymphocytes for in vivo tracking of tumor immunotherapy in murine models.Combinatorial effects of VEGFR kinase inhibitor axitinib and oncolytic virotherapy in mouse and human glioblastoma stem-like cell models.Prolonged survival in secondary glioblastoma following local injection of targeted alpha therapy with 213Bi-substance P analogue.A novel oncolytic herpes simplex virus armed with the carboxyl-terminus of murine MyD116 has enhanced anti-tumour efficacy against human breast cancer cells.HSV as A Platform for the Generation of Retargeted, Armed, and Reporter-Expressing Oncolytic Viruses

P2860

Q26767212-13842138-8380-4100-94F0-4DD2FFE14948 Q26850467-E68BB7F2-400D-4237-A7BE-DCCCD9A9BDFF Q26998111-9CDD8277-D19C-460C-B82B-E254C5A68C5E Q27021951-1D85CBD0-ED07-475E-8D3D-1B267E63C5B0 Q28072347-87A32695-9922-4B98-AD00-09F496661FDE Q35657822-874B85B1-4108-4E58-9612-88FC8694C6A4 Q36142487-D1CCC2AC-D1D0-44B1-96DA-D156CB230EA8 Q36549443-39E47554-FA73-4465-AFDD-DAD3ADDAB567 Q36575238-4A4BB9F3-6994-4703-ABE8-D875B4CD202D Q37031932-665A9374-3AC8-411D-9FD1-4183C7C513C3 Q37448116-46B27D7C-0773-4FF1-9EB5-789C3352CD28 Q38153777-7A8BA1FF-424C-4482-A169-BA1B24EDAEF7 Q38159802-17D08B2C-A45E-41A8-BDE2-04116A99BBC4 Q38212255-8A616A94-D41E-4024-8AEE-E91031AFA68D Q38400073-8A10415D-FE0F-417F-AC11-842CC03FD0E3 Q38657642-385EA61F-CE0A-451E-B57A-2A3A54DD09E3 Q38727470-0B406786-FA7B-4481-A392-C62B50FFBEC3 Q38848223-9C32E80E-58C9-496A-ACE1-CB31B4B32A64 Q39168899-4107459D-8AFD-4061-90BA-A3D0404BBFAE Q39207811-5AA7690E-1E7A-46C6-91E6-07282C2B7DE4 Q40060078-A671AA86-3267-4469-868C-01123D3B8572 Q40178043-F18C5B2A-DB72-477A-A5EF-0228AFFF631F Q41966303-F867ED39-8275-4AC7-A962-10FC36768CB0 Q42725119-19206896-7F24-43BA-B14F-0D04720E9C42 Q42934744-B57E3FF1-D278-4E5B-8A4B-279C892549C8 Q48483233-7E698D5E-E339-4339-9801-8A2610383270 Q52337612-3D3C5BE9-0D68-49C2-9C38-AE1D7E0E5C8F Q52715248-08BE63D5-2245-4F51-8FA2-AF728C2A523D Q55075584-67EA43C5-56DA-49F0-BF54-0E2FD45D3B7D Q56378150-E6CA8A2C-4E4E-443F-A27B-9D97750A9C98

P2860

Combination of oncolytic herpes simplex viruses armed with angiostatin and IL-12 enhances antitumor efficacy in human glioblastoma models.

http://www.wikidata.org/entity/Q36879211

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Combination of oncolytic herpe ...... in human glioblastoma models.

@en

type

label

Combination of oncolytic herpe ...... in human glioblastoma models.

@en

prefLabel

Combination of oncolytic herpe ...... in human glioblastoma models.

@en

P1433

Q36879211-F09DE0F6-B9D0-48C8-8085-EE32DABED36F

P1476

Q36879211-E740680E-9CF1-4A48-9B02-368EB93E08A9

P2093

Q36879211-429038B6-FD1B-4B05-B51B-ED760FB653DC

Q36879211-7E9596C1-DDC1-4F27-9EC4-14C6E46911F6

Q36879211-7F9C613F-B50D-437F-AC25-A657575BCC84

Q36879211-943F7DF6-A416-4867-9964-D3B0B6632DC2

Q36879211-955F90A9-4D69-4044-9901-69DA403A6C45

Q36879211-F501AC5F-4D26-43CA-8489-CF3AE68877F2

P2860

Q36879211-070FA29C-1DB5-4CF2-910F-BA6813438787

Q36879211-07655859-1A4C-45BF-BA0B-9EAFBE9CA3CB

Q36879211-111C7922-5EF0-48A3-AA3D-78BD942C9AA0

Q36879211-1405A06F-49A1-44C1-840B-CCF65EFACD8B

Q36879211-19D5B5DA-BD45-40FE-AFF1-92FF474D329C

Q36879211-1ACAC4ED-24BC-4EB4-9418-F9201188D727

Q36879211-1FC00313-1FD8-4885-982D-164AE43F2E60

Q36879211-29F3DB33-A0F4-4F23-9CC6-D2BB568A08E1

Q36879211-2D95E8EB-DD75-4C79-BDAF-99F02A3417D0

Q36879211-31E0AA92-6FBE-47A8-8627-12A8B2F7D713

P304

Q36879211-2589FCFB-6B11-4A69-8BF5-C78703DF8E7E

P31

Q36879211-AA72D130-2355-43F9-9540-573E4CBA88FC

P356

Q36879211-26D5FD55-B3E0-4C80-B7F8-2B8B64F3979E

P433

Q36879211-796D732F-27A1-436F-A2C9-F05FF496C922

P478

Q36879211-65888944-3FD3-4262-9532-7818403C4226

P50

Q36879211-0A9600AB-878C-4DB8-BB86-028B46EAE6DA

Q36879211-77094ACD-DA8C-4B89-8C6E-C912EB92D789

Q36879211-A812AFBD-7C31-430B-81CB-2EEC0D092EF6

P577

Q36879211-C6CD04FE-C222-4472-B837-6201778BFA59

P5875

Q36879211-B5304133-915C-47CA-85C9-9F0EB18D342F

P698

Q36879211-90D6D642-628F-4A0F-B09E-904662829E6E

P921

Q36879211-C0271F22-BFD2-4B2C-B8A8-1418BF9417F6

P932

Q36879211-2A2C5CC9-DB33-439E-9C11-33F0C3768D08

P356

P1433

P1476

Combination of oncolytic herpe ...... y in human glioblastoma models

@en

P2093

Anat O Stemmer Rachamimov

http://www.w3.org/2001/XMLSchema#string

Giulia Fulci

http://www.w3.org/2001/XMLSchema#string

Hiroaki Wakimoto

http://www.w3.org/2001/XMLSchema#string

Jason S Buhrman

http://www.w3.org/2001/XMLSchema#string

Tooba A Cheema

http://www.w3.org/2001/XMLSchema#string

Wei Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma

Flip-Flop HSV-BAC: bacterial artificial chromosome based system for rapid generation of recombinant herpes simplex virus vectors using two independent site-specific recombinases.

Cyclophosphamide increases transgene expression mediated by an oncolytic adenovirus in glioma-bearing mice monitored by bioluminescence imaging.

Depletion of peripheral macrophages and brain microglia increases brain tumor titers of oncolytic viruses

Oncolytic herpes simplex virus vectors and chemotherapy: are combinatorial strategies more effective for cancer?

Focus on central nervous system neoplasia.

Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses

Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors.

Oncolytic viruses for the therapy of brain tumors and other solid malignancies: a review.

Inhibition of tumor angiogenesis by angiostatin: from recombinant protein to gene therapy.

P304

591-599

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1593/NEO.13158

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Samuel D Rabkin

Deva S Jeyaretna

Robert L Martuza

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237014505

http://www.w3.org/2001/XMLSchema#string

P698

23730207

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

3664991

http://www.w3.org/2001/XMLSchema#string